260 related articles for article (PubMed ID: 32514629)
1. Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
Franceschini D; Cozzi L; Loi M; Franzese C; Reggiori G; Mancosu P; Clivio A; Fogliata A; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2267-2276. PubMed ID: 32514629
[TBL] [Abstract][Full Text] [Related]
2. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
4. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
5. The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study.
De Rose F; Cozzi L; Meattini I; Fogliata A; Franceschini D; Franzese C; Tomatis S; Becherini C; Livi L; Scorsetti M
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):26-34. PubMed ID: 31377082
[TBL] [Abstract][Full Text] [Related]
6. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
[No Abstract] [Full Text] [Related]
7. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
Kato T; Ono T; Narita Y; Komori S; Murakami M
Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
[TBL] [Abstract][Full Text] [Related]
9. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
10. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies.
Liu C; Bhangoo RS; Sio TT; Yu NY; Shan J; Chiang JS; Ding JX; Rule WG; Korte S; Lara P; Ding X; Bues M; Hu Y; DeWees T; Ashman JB; Liu W
J Appl Clin Med Phys; 2019 Jul; 20(7):15-27. PubMed ID: 31112371
[TBL] [Abstract][Full Text] [Related]
12. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp.
Mizuno T; Tomita N; Takaoka T; Tomida M; Fukuma H; Tsuchiya T; Shibamoto Y
Technol Cancer Res Treat; 2021; 20():1533033820985866. PubMed ID: 33517860
[TBL] [Abstract][Full Text] [Related]
14. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
[TBL] [Abstract][Full Text] [Related]
15. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
16. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
17. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
19. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
20. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
Front Oncol; 2019; 9():1456. PubMed ID: 31998635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
